🟡 Medium ImpactRegulation
Vivimed Labs trading suspension revoked; resumes December 18
Vivimed Labs trading suspension revoked by BSE and NSE. The stock was under trading suspension but regulators have lifted the ban, allowing normal trading to resume on December 18. This regulatory clearance enables traders to re-enter positions in the stock after the suspension period. The resumption marks a key milestone for shareholders awaiting liquidity restoration.
📊 STOCKS: VIVIMED | 🏢 SECTOR: CapitalMarkets | #MEDIUMIMPACT #trading-suspension
#trading-suspension#BSE#NSE#stock-resumption
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →